优秀学术报告PPT示例.pptVIP

Chemistry in biomedicine and Drug discovery Professor ari Koskinen Helsinki University of Technology 11.03.2005  Enabling technologies for Medicime and Biology M 08额W明e0 New synthetic Natural product technolo Ari Koskinen HELSINKI UNIVERSITY OF TECHNOLOGY Laboratory of Organic Chemistry  人人位 OLOGY 人人 ORGANIC SYNTHE Heneral contributions to science and society ORGANOCATALYS  New Chemical Entities vs RD Expedinture 485s672849127131521613721l024 0.70 40 FDA entities approved bt Numbers A-Ratio: $/No 10 8687888990919293949596979899 Tote: Ethical pharmaceuticals only. Expenditures worldwide by U.S. - owned research-based pharmaceutical companies CEN January 17, 2000, Food Drug Administration, Pharmaceutical Research Manufacturers of America: PhRMA Annual Survey 2000 Ari Koskinen HELSINKI UNIVERSITY OF TECHNOLOGY Laboratory of Organic Chemistry  New Drug development MEAN APPROVAL T MES FOR NEW DRUGS. 1989-1999 an approvel time (months) 232330262522 total 昌裂 1901911s299319941995199 Source: U.S. Food and DTu Administr Ari Koskinen HELSINKI UNIVERSITY OF TECHNOLOGY Laboratory of Organic Chemistry